InterVenn Shifts Direction Again, From Immunotherapy Focus to Cancer Screening
Just months after launching a test for guiding immunotherapy, the glycoproteomics firm has switched priorities to a colorectal cancer screening assay.
Source: 360dx.com
Stay updated with breaking news from Simplipro Colon. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Just months after launching a test for guiding immunotherapy, the glycoproteomics firm has switched priorities to a colorectal cancer screening assay.